Cite

HARVARD Citation

    Dias, M. et al. (2019). Fibroblast Growth Factor 2 lethally sensitizes cancer cells to stress‐targeted therapeutic inhibitors. Molecular oncology. 13 (2), pp. 290-306. [Online]. 
  
Back to record